<PAGE> 1
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------
Schedule 14D-1
(Amendment No. 2/Final Amendment)
Tender Offer Statement Pursuant to Section 14(d)(1)
Of the Securities Exchange Act of 1934
and
Schedule 13D
Under the Securities Exchange Act of 1934
---------------------------
AMERICAN MEDSERVE CORPORATION
(Name of Subject Company)
---------------------------
OMNICARE ACQUISITION CORP.
a wholly owned subsidiary of
OMNICARE, INC.
(Bidders)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
---------------------------
027448109
(CUSIP Number of Class of Securities)
Joel F. Gemunder
President
Omnicare, Inc.
50 East RiverCenter Boulevard
Covington, Kentucky 41011
(606) 291-6800
(Names, Addresses and Telephone Numbers of Persons Authorized
to Receive Notices and Communications on Behalf of Bidders)
WITH COPIES TO:
Morton A. Pierce
Dewey Ballantine
1301 Avenue of the Americas
New York, New York 10019
(212) 259-8000
===============================================================================
<PAGE> 2
- --------------------------------------------------------------------------------
CUSIP No. 027448109 Page _____ of _____ Pages
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON: OMNICARE ACQUISITION CORP.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 31-1554409
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCES OF FUNDS
AF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(e) OR 2(f) [ ]
- ----------- --------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
- --------------------------------------------------------------------------------
7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,868,156 (including 129,481 Shares tendered by means of
guaranteed delivery)
- --------------------------------------------------------------------------------
8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
97.1%
- --------------------------------------------------------------------------------
10 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE> 3
- -------------------------------------------------------------------------------
CUSIP No. 027448109 Page _____ of _____ Pages
- -------------------------------------------------------------------------------
- ----------- -------------------------------------------------------------------
1 NAME OF REPORTING PERSON: OMNICARE, INC.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: 31-1001351
- ----------- --------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCES OF FUNDS
WC/BK
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(e) OR 2(f) [ ]
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
State of Delaware
- --------------------------------------------------------------------------------
7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,868,156 (including 129,481 Shares tendered by means of
guaranteed delivery)
- --------------------------------------------------------------------------------
8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES [ ]
- --------------------------------------------------------------------------------
9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
97.1%
- --------------------------------------------------------------------------------
10 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
<PAGE> 4
Omnicare Acquisition Corp., a Delaware corporation (the "Purchaser")
and a wholly owned subsidiary of Omnicare, Inc., a Delaware corporation
("Parent"), and Parent hereby further amend and supplement their Tender Offer
Statement on Schedule 14D-1, as amended (the "Schedule 14D-1"), relating to the
Purchaser's offer to purchase all of the outstanding shares of common stock, par
value $0.01 per share (the "Shares"), of American Medserve Corporation, a
Delaware corporation (the "Company"). Capitalized terms used herein and not
otherwise defined shall have the meanings set forth in the Schedule 14D-1 or the
Offer to Purchase filed as an exhibit thereto.
ITEM 6. INTEREST IN SECURITIES OF THE SUBJECT COMPANY
The information set forth in paragraphs (a) and (b) of Item 6 of the Schedule
14D-1 is hereby amended and supplemented as follows:
The Offer expired at 12:00 midnight, New York City time, on September
11, 1997. According to a preliminary count by the Depositary, there were validly
tendered 11,868,156 Shares (including 129,481 Shares subject to guarantees of
delivery). The Shares so tendered represent approximately 97.1 percent of the
outstanding Shares. The Purchaser accepted for payment all such Shares validly
tendered according to the terms of the Offer.
ITEM 10. ADDITIONAL INFORMATION
Pursuant to the Merger Agreement, the Purchaser intends to effect the
Merger in which each remaining Share will be converted into the right to receive
$18.00 in cash, without interest thereon.
A press release issued by Parent is filed as Exhibit (a) (10) and is
incorporated herein by reference.
ITEM 11. MATERIAL TO BE FILED AS EXHIBITS.
(a)(10) Form of press release issued by Parent on September 12, 1997.
<PAGE> 5
SIGNATURE
After due inquiry and to the best of its knowledge and belief, each
of the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Dated: September 12, 1997
OMNICARE ACQUISITION CORP.
By: /s/ Joel F. Gemunder
-----------------------
Joel F. Gemunder
President
OMNICARE, INC.
By: /s/ Joel F. Gemunder
------------------------
Joel F. Gemunder
President
<PAGE> 6
Exhibit Index
Exhibit Description
- ------- -----------
(a)(10) Form of press release issued by Parent on
September 12, 1997
<PAGE> 1
Exhibit (a) (10)
For Immediate Release
Contacts:
Cheryl D. Hodges
(513) 762-6967
or
Gary L. Rhodes
(513) 762-6660
OMNICARE COMPLETES TENDER OFFER
FOR AMERICAN MEDSERVE CORPORATION
CINCINNATI, OHIO, SEPTEMBER 12, 1997. . . Omnicare, Inc. (NYSE: OCR) today
announced it has completed its cash tender offer for all of the outstanding
shares of common stock of American Medserve Corporation (Nasdaq: AMCI) at a
price of $18.00 per share. The tender offer expired, as scheduled, at midnight
New York City time on September 11, 1997.
Omnicare's wholly owned subsidiary, Omnicare Acquisition Corp., today
accepted for payment all of the approximately 11,868,156 shares of American
Medserve Corporation's common stock that had been validly tendered, including
approximately 129,481 shares tendered pursuant to notices of guaranteed
delivery. The shares tendered represent approximately 97% of the outstanding
shares of American Medserve Corporation. Omnicare and American Medserve
Corporation now will complete a merger under which the remaining outstanding
shares of American Medserve Corporation common stock will be converted into the
right to receive $18.00 per share in cash.
"We're delighted with the successful completion of our cash tender offer
for American Medserve Corporation," said Joel F. Gemunder, Omnicare president.
"We are confident that the combination of Omnicare and American Medserve
Corporation will create the nations premier institutional pharmacy provider with
the broad geographic presence, innovative clinical programs, considerable
resources and pharmacy management experience necessary to capitalize on future
growth opportunities. Working together, we can provide the basis for superior
geriatric pharmaceutical care that leads to better health outcomes in the most
cost-effective manner."
Omnicare is a leading independent provider of professional pharmacy and
related consulting services for long-term care facilities such as nursing
homes, retirement centers and other institutional health care facilities.
American Medserve Corporation, based in Naperville, Illinois, provides
comprehensive pharmacy and related services to approximately 51,400 residents
in 720 long-term care facilities in 11 states. Additionally, American Medserve
Corporation is a joint venture partner with an affiliate of The Evangelical
Lutheran Good Samaritan Society, which ranks as the nation's fifth-largest
nursing home operator, serving 27,000 residents.
With the completion of this acquisition, Omnicare will provide pharmacy and
related consulting services to approximately 413,000 residents in over 5,100
long-term care facilities in 35 states. Based on revenues for Omnicare and
American Medserve Corporation for the quarter ended June 30, 1997, annualized
revenues of the combined companies are in excess of $975.0 million.
For more information on Omnicare, Inc. via the Internet, including a full
menu of news releases, visit our Corporate News on The Net site at
http://www.businesswire.com/cnn/ocr.htm
